re: Ann: EU Marketing Authorisation Applicati... I understand that Pulmozyme was rejected first time around by EMA.
Does anyone know the reasons behind this and also why it was approved on appeal?
On the safety front, mannitol has a good solid profile given that the compound has been used extensively for many treatments including head trauma etc.
Ann: EU Marketing Authorisation Application Revie, page-7
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
